SL
VTVT icon

Siren LLC’s vTv Therapeutics VTVT Stock Holding History

Siren LLC’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.14M Hold
163,000
– – 0.12% 85
2026
Q1 		$6.46M Hold
163,000
– – 0.18% 70
2025
Q4 		$6.52M Hold
163,000
– – 0.19% 71
2025
Q3 		$3.81M Buy
+163,000
New +$2.86M 0.15% 74

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Siren LLC's VTVT Position: Q2 2026 in Review

Siren LLC held its vTv Therapeutics (VTVT) position steady in Q2 2026 at 163,000 shares worth $6.14M. The position accounts for 0.12% of the portfolio, ranked #85.

Siren LLC first reported a position in VTVT in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.52M in Q4 2025. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Siren LLC held 163,000 shares of vTv Therapeutics worth $6.14M as of Q2 2026.
  • Siren LLC left its vTv Therapeutics share count unchanged in Q2 2026.
  • vTv Therapeutics made up 0.12% of Siren LLC's portfolio in Q2 2026, its #85 holding.
  • Siren LLC first reported a position in vTv Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Siren LLC's vTv Therapeutics position peaked at $6.52M in Q4 2025.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.